[MOL] Triapine inhibitor infor for solid tumors and acute myelogenous leukemia.....

["Lillian" <firefly@islc.net>]

* First Clinical Study of Triapine Completed in Cancer Patients
    Triapine is a potent ribonucleotide reductase inhibitor that has the
potential for treating patients with solid tumors and acute myelogenous
leukemia. Recent phase I clinical trial results showed that there were no
clinically significant toxicities associated with Triapine, even at the
highest dose level.

Professional Version:
http://pharminfo.com//pubs/druginfoline/druginfo2_325p.html
Consumer Version:
http://pharminfo.com//pubs/druginfoline/druginfo2_325c.html

Warmly, lillian

 

We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html

 

  ( Very informational, good tips, Molers pictures, art work and much more....